Correlation Engine 2.0
Clear Search sequence regions


  • 5 utr (1)
  • ABCG2 (1)
  • Ago2 (1)
  • al 1 (1)
  • allele (2)
  • angiogenesis (6)
  • apelin receptor (1)
  • apoptosis (5)
  • biogenesis (1)
  • birth weight (1)
  • blood (4)
  • brain tumors (1)
  • breast cancer (1)
  • cajal bodies (1)
  • cancer (2)
  • case (1)
  • CDKN1A (6)
  • cell cycle (1)
  • cell membrane (2)
  • cellular (1)
  • cGMP (1)
  • chondrosarcoma (1)
  • cluster (71)
  • colostrum (1)
  • concept (1)
  • consensus sequence (1)
  • contains (3)
  • cpg islands (1)
  • CXCR4 (1)
  • cytokines (1)
  • dapk2 (1)
  • data analysis (1)
  • DMR (1)
  • dna sequence (1)
  • egf (1)
  • elastin (1)
  • embryo (3)
  • endothelium (1)
  • EphB4 (1)
  • ethnic (1)
  • exocytosis (1)
  • exons (2)
  • extracellular matrix (2)
  • extracellular space (1)
  • factor (13)
  • fetal growth (1)
  • fetal mortality (1)
  • fibrin (1)
  • FLT1 (2)
  • fluids appear (1)
  • FOXL2 (1)
  • fusion cell (1)
  • gametogenesis (1)
  • genes (20)
  • glial cells (1)
  • growth factor (1)
  • growth factor receptors (1)
  • hbd (3)
  • help (1)
  • hemolysis (1)
  • hepatocellular carcinoma (2)
  • human (6)
  • human body (1)
  • human chromosome (1)
  • hypoxia (2)
  • igf (1)
  • integrins (1)
  • interview (1)
  • ischemia (1)
  • ITGb4 (1)
  • ligand (2)
  • LIN28 (1)
  • LIN28B (4)
  • lipids (1)
  • liver (1)
  • long- term effects (1)
  • lung adenocarcinoma (1)
  • macrophages (1)
  • metastasis (1)
  • micrornas (148)
  • microvilli (1)
  • miR 16 (1)
  • miR516a (1)
  • MMP2 (2)
  • monocytes (1)
  • mortality (3)
  • mother (3)
  • mother fetus relationship (1)
  • mrna processes (1)
  • multivesicular bodies (1)
  • myeloma (1)
  • necrosis (1)
  • neutrophil (1)
  • newborns (1)
  • NF kappa B (2)
  • nitric oxide (2)
  • nk cells (2)
  • NLRP3 (1)
  • NR4A2 (1)
  • nucleic acids (1)
  • nucleotides (1)
  • ovarian cancer (1)
  • pathogenesis (2)
  • patient (5)
  • placenta (33)
  • placenta weight (1)
  • plasma (12)
  • plasma proteins (1)
  • PlGF (1)
  • postpartum (1)
  • postpartum women (1)
  • pre- eclampsia (59)
  • pregnancy (25)
  • pregnant women (10)
  • primates (1)
  • PRKG1 (1)
  • protein genes (1)
  • proteins family (1)
  • proteinuria (1)
  • Rap1b (2)
  • receptor growth factor (1)
  • research (4)
  • risk factors (1)
  • rna (13)
  • rna polymerase (1)
  • rs55765443 (1)
  • saliva (1)
  • serum (14)
  • smooth muscles (1)
  • stem cells (2)
  • syncytin 1 (1)
  • syncytiotrophoblast (5)
  • t lymphocytes (2)
  • target genes (9)
  • tears (1)
  • testes (1)
  • TET1 (1)
  • therapies (1)
  • thrombocytopenia (1)
  • thyroid adenomas (1)
  • time symptom onset (1)
  • TNIP1 (1)
  • trophoblast (17)
  • uterus (1)
  • vascular endothelium (2)
  • vascular factor (2)
  • VEGF (3)
  • weight (1)
  • WNT receptor (1)
  • women (5)
  • Sizes of these terms reflect their relevance to your search.

    Pre-eclampsia is a placenta-related complication occurring in 2-10% of all pregnancies. miRNAs are a group of non-coding RNAs regulating gene expression. There is evidence that C19MC miRNAs are involved in the development of the placenta. Deregulation of chromosome 19 microRNA cluster (C19MC) miRNAs expression leads to impaired cell differentiation, abnormal trophoblast invasion and pathological angiogenesis, which can lead to the development of pre-eclampsia. Information was obtained through a review of articles available in PubMed Medline. Articles on the role of the C19MC miRNA in the development of pre-eclampsia published in 2009-2022 were analyzed. This review article summarizes the current data on the role of the C19MC miRNA in the development of pre-eclampsia. They indicate a significant increase in the expression of most C19MC miRNAs in placental tissue and a high level of circulating fractions in serum and plasma, both in the first and/or third trimester in women with PE. Only for miR-525-5p, low levels of plasma expression were noted in the first trimester, and in the placenta in the third trimester. The search for molecular factors indicating the development of pre-eclampsia before the onset of clinical symptoms seems to be a promising diagnostic route. Identifying women at risk of developing pre-eclampsia at the pre-symptomatic stage would avoid serious complications in both mothers and fetuses. We believe that miRNAs belonging to cluster C19MC could be promising biomarkers of pre-eclampsia development.

    Citation

    Ilona Jaszczuk, Izabela Winkler, Dorota Koczkodaj, Maciej Skrzypczak, Agata Filip. The Role of Cluster C19MC in Pre-Eclampsia Development. International journal of molecular sciences. 2022 Nov 10;23(22)

    Expand section icon Mesh Tags

    Expand section icon Substances


    PMID: 36430313

    View Full Text